Suchergebnisse - "Fournel, Pierre"

PubPharm (143)

1

Spread Through Air Spaces in Stage I to III Resected Lung Adenocarcinomas : Should the Presence of Spread Through Air Spaces Lead to an Upstaging?

enthalten in: The American journal of surgical pathology | 2024

von Laville, D. | Désage, A. | Fournel, P. | +6

2

COVID-19 Outbreak Impact on Cancer Multidisciplinary Team Meetings. A Multicenter French Experience

enthalten in: Cancer investigation | 2024

von Bouleftour, W. | Mondiere-Wichurski, A. | Fournel, P. | +1

3

Hyalinizing clear cell carcinoma of the lung with EWSR1::CREM fusion

enthalten in: Histopathology | 2023

von Grosjean, V. | Fournel, P. | Picot, T. | +2

4

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world : impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Descourt, R. | Greillier, L. | Perol, M. | +17

5

Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma : Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Racadot, S. | Thennevet, I. | Ouldbey, Y. | +18

6

Adjuvant chemotherapy for completely resected IIA-IIIA non-small cell lung cancer : compliance to guidelines, safety and efficacy in real-life practice

enthalten in: Translational lung cancer research | 2022

von Désage, A. | Tissot, C. | Bayle-Bleuez, S. | +12

CommentIn: Transl Lung Cancer Res. 2023 Feb 28;12(2):204-206. - PMID 36895929

7

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

enthalten in: Cancer immunology immunotherapy | 2022

von Descourt, R. | Greillier, L. | Perol, M. | +17

8

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

enthalten in: Cancer immunology immunotherapy | 2022

von Descourt, R. | Greillier, L. | Perol, M. | +17

9

Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma

enthalten in: Cancers | 2022

von Dagher, S. | Sulaiman, A. | Bayle-Bleuez, S. | +6

10

Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Petat, A. | Dansin, E. | Calcagno, F. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]